Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weber, T.
Right arrow Articles by Neuzil, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, T.
Right arrow Articles by Neuzil, J.
Clinical Cancer Research Vol. 8, 863-869, March 2002
© 2002 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Vitamin E Succinate Is a Potent Novel Antineoplastic Agent with High Selectivity and Cooperativity with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (Apo2 Ligand) in Vivo1

Tobias Weber, Min Lu, Ladislav Andera, Harald Lahm, Nina Gellert, Marc W. Fariss, Vladimir Korinek, Wolfgang Sattler, David S. Ucker, Alexei Terman, Andreas Schröder, Wolfgang Erl, Ulf T. Brunk, Robert J. Coffey, Christian Weber and Jiri Neuzil2

Institute for Prevention of Cardiovascular Diseases, Ludwig Maximilians University, Munich, 80336 Germany [T. W., N. G., A. S., W. E., C. W., J. N.]; Division of Pathology II, University Hospital, Linköping SE-581 85, Sweden [A. T., U. T. B., J. N.]; Department of Medicine and Cell Biology, Vanderbilt University, Nashville, Tennessee 37235 [M. L., R. J. C.]; Institute of Molecular Genetics, Czech Academy of Sciences, Prague, 14220 Czech Republic [L. A., V. K.]; Institute of Molecular Animal Breeding, Ludwig Maximilians University, Munich, 81377 Germany [H. L.]; Department of Pharmaceutical Sciences, Washington State University, Pullman, Washington 99164 [M. W. F.]; Institute of Medical Biochemistry, University of Graz, 8010 Graz, Austria [W. S.]; Department of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, Illinois 60612 [D. S. U.]; and Department of Cardiovascular Molecular Biology, University Hospital, Aachen, 52057 Germany [C. W.]

{alpha}-Tocopheryl succinate ({alpha}-TOS), a redox-inactive analogue of vitamin E, is a strong inducer of apoptosis, whereas {alpha}-tocopherol ({alpha}-TOH) lacks apoptogenic activity (J. Neuzil et al., FASEB J., 15: 403–415, 2001). Here we investigated the possible antineoplastic activities of {alpha}-TOH and {alpha}-TOS and further explored the potential of {alpha}-TOS as an antitumor agent. Using nude mice with colon cancer xenografts, we found that {alpha}-TOH exerted modest antitumor activity and acted by inhibiting tumor cell proliferation. In contrast, {alpha}-TOS showed a more profound antitumor effect, at both the level of inhibition of proliferation and induction of tumor cell apoptosis. {alpha}-TOS was nontoxic to normal cells and tissues, triggered apoptosis in p53-/- and p21Waf1/Cip1(-/-) cancer cells, and exerted a cooperative proapoptotic activity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) due to differences in proapoptotic signaling. Finally, {alpha}-TOS cooperated with tumor necrosis factor-related apoptosis-inducing ligand in suppression of tumor growth in vivo. Vitamin E succinate is thus a potent and highly specific anticancer agent and/or adjuvant of considerable therapeutic potential.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
X. Gu, X. Song, Y. Dong, H. Cai, E. Walters, R. Zhang, X. Pang, T. Xie, Y. Guo, R. Sridhar, et al.
Vitamin E Succinate Induces Ceramide-Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma In vitro and In vivo
Clin. Cancer Res., March 15, 2008; 14(6): 1840 - 1848.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L.-F. Dong, E. Swettenham, J. Eliasson, X.-F. Wang, M. Gold, Y. Medunic, M. Stantic, P. Low, L. Prochazka, P. K. Witting, et al.
Vitamin E Analogues Inhibit Angiogenesis by Selective Induction of Apoptosis in Proliferating Endothelial Cells: The Role of Oxidative Stress
Cancer Res., December 15, 2007; 67(24): 11906 - 11913.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Neuzil, M. Tomasetti, Y. Zhao, L.-F. Dong, M. Birringer, X.-F. Wang, P. Low, K. Wu, B. A. Salvatore, and S. J. Ralph
Vitamin E Analogs, a Novel Group of "Mitocans," as Anticancer Agents: The Importance of Being Redox-Silent
Mol. Pharmacol., May 1, 2007; 71(5): 1185 - 1199.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X.-F. Wang, M. Birringer, L.-F. Dong, P. Veprek, P. Low, E. Swettenham, M. Stantic, L.-H. Yuan, R. Zobalova, K. Wu, et al.
A Peptide Conjugate of Vitamin E Succinate Targets Breast Cancer Cells with High ErbB2 Expression
Cancer Res., April 1, 2007; 67(7): 3337 - 3344.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-W. Shiau, J.-W. Huang, D.-S. Wang, J.-R. Weng, C.-C. Yang, C.-H. Lin, C. Li, and C.-S. Chen
{alpha}-Tocopheryl Succinate Induces Apoptosis in Prostate Cancer Cells in Part through Inhibition of Bcl-xL/Bcl-2 Function
J. Biol. Chem., April 28, 2006; 281(17): 11819 - 11825.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Donapaty, S. Louis, E. Horvath, J. Kun, S. M. Sebti, and M. P. Malafa
RRR-{alpha}-Tocopherol succinate down-regulates oncogenic Ras signaling.
Mol. Cancer Ther., February 1, 2006; 5(2): 309 - 316.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Stapelberg, N. Gellert, E. Swettenham, M. Tomasetti, P. K. Witting, A. Procopio, and J. Neuzil
{alpha}-Tocopheryl Succinate Inhibits Malignant Mesothelioma by Disrupting the Fibroblast Growth Factor Autocrine Loop: MECHANISM AND THE ROLE OF OXIDATIVE STRESS
J. Biol. Chem., July 8, 2005; 280(27): 25369 - 25376.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. Zu, L. Hawthorn, and C. Ip
Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by {alpha}-tocopheryl succinate in human prostate cancer cells
Mol. Cancer Ther., January 1, 2005; 4(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
K. A. Lawson, K. Anderson, M. Simmons-Menchaca, J. Atkinson, L. Sun, B. G. Sanders, and K. Kline
Comparison of Vitamin E Derivatives {alpha}-TEA and VES in Reduction of Mouse Mammary Tumor Burden and Metastasis
Experimental Biology and Medicine, October 1, 2004; 229(9): 954 - 963.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Anderson, M. Simmons-Menchaca, K. A. Lawson, J. Atkinson, B. G. Sanders, and K. Kline
Differential Response of Human Ovarian Cancer Cells to Induction of Apoptosis by Vitamin E Succinate and Vitamin E Analogue, {alpha}-TEA
Cancer Res., June 15, 2004; 64(12): 4263 - 4269.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Zu and C. Ip
Synergy between Selenium and Vitamin E in Apoptosis Induction Is Associated with Activation of Distinctive Initiator Caspases in Human Prostate Cancer Cells
Cancer Res., October 15, 2003; 63(20): 6988 - 6995.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Yu, B. G. Sanders, and K. Kline
RRR-{alpha}-Tocopheryl Succinate-induced Apoptosis of Human Breast Cancer Cells Involves Bax Translocation to Mitochondria
Cancer Res., May 15, 2003; 63(10): 2483 - 2491.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
K. N. Prasad, B. Kumar, X.-D. Yan, A. J. Hanson, and W. C. Cole
{alpha}-Tocopheryl Succinate, the Most Effective Form of Vitamin E for Adjuvant Cancer Treatment: A Review
J. Am. Coll. Nutr., April 1, 2003; 22(2): 108 - 117.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
R. Brigelius-Flohe, F. J Kelly, J. T Salonen, J. Neuzil, J.-M. Zingg, and A. Azzi
The European perspective on vitamin E: current knowledge and future research
Am. J. Clinical Nutrition, October 1, 2002; 76(4): 703 - 716.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.